Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

Capecitabine 5 Bevacizumab 5 Radiotherapy 3 Oxaliplatin 3 olaparib 2 durvalumab 2 darolutamide 2 dalpiciclib 2 atezolizumab 2 apatinib 2 anlotinib 2 Surgical Procedures, Operative 2 Standard of Care 2 Radiosurgery 2 Leucovorin 2 Laparoscopy 2 Immunotherapy 2 Fluorouracil 2 Drug Therapy 2 trametinib 1 toripalimab 1 tislelizumab 1 spartalizumab 1 pyrotinib 1 pomalidomide 1 palbociclib 1 nilotinib 1 ledipasvir, sofosbuvir drug combination 1 ledipasvir 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × glasdegib × 90 days × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡